Innovative BioResearch AMA Transcript with BSCnews

BSC.NEWS recently hosted an AMA with Innovative Bioresearch Ltd CEO Dr. Jonathan Fior! Please find below the full transcript.

KDOT (AMA Host): Welcome, Jonathan! Thanks for allocating some time to do an AMA for the community.

JONATHAN: Thank you so much for this amazing opportunity.

KDOT (AMA Host): Okay! Let's pop it off with questions a lot of people have been wanting to know.

Q1: Give us an in-depth summary of what your project is about?

JONATHAN: First off, thank you so much for this opportunity to showcase our project. Innovative Bioresearch Ltd. is a biotech company founded by Italian research scientist Dr. Jonathan Fior with the goal of bringing innovation to the field of HIV, cancer and regeneration research. Notably, we are developing “SupT1 cell infusion therapy”, a cell-based HIV treatment estimated to be a lot cheaper than conventional antiretroviral therapy (ART) and than any gene therapy offered by other competitors. The treatment is based on the groundbreaking HIV cure research performed by Dr. Jonathan Fior (Fior J. SupT1 Cell Infusion as a Possible Cell-Based Therapy for HIV: Results from a Pilot Study in Hu-PBMC BRGS Mice. Vaccines. 2016;4:13 There were 36.7million people infected by HIV globally in 2016; 17.5million of which were left untreated, according to UNAIDS. Our mission is to develop a low cost cell-based therapy solution for HIV to allow access to the treatment for those individuals who are normally left untreated due to social and/or economic limitations. We believe that this is exactly what the blockchain should be about, having the collectivity solving a global issue with decentralization means as a cryptocurrency. We aim to build a DeFi ecosystem on top of actual biomedical research, with real world application in vaccine development. We call it “DeFi science”. So this is what INNBC is about and our mission, vision, and long term goal.

KDOT (AMA Host): Right, so...

Q2: What does your team consist of?

JONATHAN: First off, we would like to stress the fact that we are not anonymous. We believe that this is important. We just love this kind of transparency. The core team is composed of 4 members and we are based in Italy. The CEO, Dr. Jonathan Fior (Research Scientist and Blockchain Developer), our Marketing Director, Enrico Durante (which is also a blockchain developer), our Social Media Manager, Davide Bosetti (with a strong background in the entertainment musical industry), and our Legal Expert, Alessandro Gatti. We also have additional staff we hire for performing specific tasks.

KDOT (AMA Host): Okay, thats good to know! Yes, I have my own views on anon projects. Perfect!

Q3: So, with everything you're trying to achieve, why a token? What are the tokenomics?

JONATHAN: At its core, INNBC is meant to be used as a means of payment to access our medical products. As such, by owning INNBC you own access to such products, with a token backed by actual pharmaceuticals. INNBC is also going to be the governance token for our DeFi ecosystem. This means it will be used for voting purposes, but also to access stuff like NFTs, gaming, and all the other DeFi products in development. With InnonativeBioresearchSwap, our upcomig DEX, we also aim INNBC to be a widely used pair for many projects on Binance Smart Chain.

Side Q: Okay, so if you're trying to develop vaccinations, why are you looking to take the route of NFTs and Swaps, e.t.c.?

JONATHAN: That is a good question, thank you! It's because we believe that it is important to appeal to traditional users building a strong userbase that will then also contribute to scientific development. Here, by using our DEX and farm you would not just be farming a token, but actively contributing to “farming” actual drugs and therapies for diseases such as HIV, Cancer and COVID. Just by simply using our dApps, you would be actively contributing to supporting our vaccine research. Isn’t this amazing? This is something unprecedented in DeFi and crypto. We call this “DeFi science”.

Side Q: Do you mean by people using the product they contribute to your research by fees, e.t.c.?

JONATHAN: All the liquidity that is generated by the users will also support the research. As the token direcly funds the research activity, all the profits we can have by the market making activity are devoted to supporting the vaccine research.

KDOT (AMA Host): Okay! That leads on to...

Q4: Why did you airdrop 1000 tokens to all wallets?

JONATHAN: Simply because we wanted to provide a free start into our ecosystem. We believe that is a nice way to be introduced to our project. So they can start to use the token in the upcoming DEX, farm, and all the other products we are developing.

KDOT (AMA Host): Okay, makes sense!

Q5: Liquidity is shallow on PCS, any reason?

JONATHAN: Nothing worthwhile ever comes easy. First, we focused on developing an actual product (years of hard work to develop and publish our research) and only then (which is very soon) we planned to issue our dApps (starting with InnovativeBioresearchSwap), which should impact the liquidity. Key difference here is building on top of actual pharmaceuticals.

KDOT (AMA Host): Perfect!

Q6: Why have you chosen to use the Blockchain for your project?

JONATHAN: There are some specific features of Blockchain technology that are very useful for scientific research.

- Immutability: Scientific data need to be immutable. Once a study is peer reviewed and published, its data must be permanently stored and never altered. In the blockchain, all data is stored in every single node, never ceasing to exist, and always staying on the blockchain. It is immutability that gives the blockchain its openness and BFT (Byzantine Fault Tolerance).

- Decentralization: The blockchain is designed to be distributed and synchronized across networks, making data freely available to anyone. We believe that scientific data should be shared and not being hidden behind a firewall.

- Security: The kind of transactions that can be performed are strictly defined in advance and stored in the blockchain as “smart contracts”; this prevents fraudulent data from being added to the blockchain thus ensuring integrity of the database. By contrast, it would be much easier to compromise a centralized database.